drugset / Trial / NCT01720537
A Study To Assess The Safety Of PF-05335810 In Hypercholesterolemic Subjects
RandomizedSingle-groupDouble-blindBasic science
Summary
This study is to evaluate the safety, tolerability and immunogenicity of single, ascending or multiple fixed subcutaneous and intravenous administrations of PF 05335810 to hypercholesterolemic subjects when added on to a daily statin dose.
Timeline
- Start
- 2012-07
- Primary completion
- 2013-10
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bococizumab | Monoclonal antibody | — | Subcutaneous |
| Subject | RALPANCIZUMAB | Monoclonal antibody | — | Subcutaneous |